A clinical trial testing TG Therapeutics‘ CD20 inhibitor Briumvi (ublituximab-xiiy) in children with relapsing forms of multiple…
Articles by Lindsey Shapiro, PhD
Immunic Therapeutics‘ experimental oral therapy vidofludimus calcium can target key mechanisms underlying disease progression in multiple sclerosis…
A Canadian study is challenging the growing belief that previous infection with the Epstein-Barr virus (EBV) is necessary for…
The investigational BTK inhibitor tolebrutinib did not lower the risk of confirmed disability progression compared with placebo in people…
The investigational BTK inhibitor fenebrutinib was as effective as the approved therapy Ocrevus (ocrelizumab) at reducing the risk…
Researchers have developed a mouse model designed to reflect the disability worsening that occurs in the absence of relapses for…
Researchers and clinicians are gathering in San Diego and online for the 11th annual Americas Committee for Treatment and…
Some older people with multiple sclerosis (MS), namely those older than 60, may be able to safely discontinue…
A stem cell transplant may offer better long-term results for people with aggressive multiple sclerosis (MS) compared with standard…
A new model using artificial intelligence (AI) suggests that multiple sclerosis (MS) progression is better viewed along a single…
While certain autoimmune diseases are linked to an increased risk of digestive system cancers, people with multiple sclerosis (MS)…
More people with multiple sclerosis (MS) are using diet modifications to boost well-being and to manage symptoms, but there’s…
Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple sclerosis…
A global clinical trial has been launched to evaluate the oral therapy candidate BMS-986368 for treating spasticity — muscle…
Researchers have developed a blood test to identify people at risk of developing multiple sclerosis (MS) years before the…
Artificial intelligence (AI)-powered algorithms to analyze data collected on a smartphone app could predict whether a person with multiple…
The use of B-cell depleting therapies does not increase the risk of an infection with COVID-19 among people with…
A particular finding on an MRI scan, called the central vein sign (CVS), is sufficient to support a multiple…
A pair of scientists have been awarded a 2025 Breakthrough Prize in Life Sciences for their work uncovering factors that…
Clinical improvements in vision and cognition linked to the use of treatment candidate CNM-Au8 were correlated with signs of…
A high dose cholecalciferol, a form of vitamin D, significantly reduced the risk of further disease activity in people…
Evidence of neurological damage over time — known as dissemination in time, or DIT — may not be necessary to…
Neurons, also called nerve cells, collected from brain lesions of people with multiple sclerosis (MS) were found to…
Proposed revisions to the McDonald criteria, a set of diagnostic guidelines for multiple sclerosis (MS), may help diagnose…
Note: This study was updated March 3, 2025, to correct that a ketogenic diet is a low-carbohydrate, high-fat diet.
Treatment with Ocrevus (ocrelizumab) may have a beneficial effect on paramagnetic rim lesions — known as PRL, these are…
Immune cells from people with multiple sclerosis (MS) exhibit distinct gene activity just before patients have a disease…
Relapsing-remitting multiple sclerosis (RRMS) patients with low educational attainment are more likely to delay the start of disease-modifying…
A three-month course of acupuncture was associated with gains in certain aspects of cognition for people with relapsing-remitting multiple…
A 14-week regimen of physical therapy combined with PoNS — a neurostimulator device used to improve mobility — led…